Cargando…

The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature

BACKGROUND: Lipodystrophy syndromes are rare disorders of variable body fat loss associated with potentially serious metabolic complications. Familial partial lipodystrophy (FPLD) is mostly inherited as an autosomal dominant disorder. Renal involvement has only been reported in a limited number of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ru-Xuan, Zhang, Lei, Ye, Wei, Wen, Yu-Bing, Si, Nuo, Li, Hang, Li, Ming-Xi, Li, Xue-Mei, Zheng, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946515/
https://www.ncbi.nlm.nih.gov/pubmed/29747582
http://dx.doi.org/10.1186/s12882-018-0913-6
_version_ 1783322213999443968
author Chen, Ru-Xuan
Zhang, Lei
Ye, Wei
Wen, Yu-Bing
Si, Nuo
Li, Hang
Li, Ming-Xi
Li, Xue-Mei
Zheng, Ke
author_facet Chen, Ru-Xuan
Zhang, Lei
Ye, Wei
Wen, Yu-Bing
Si, Nuo
Li, Hang
Li, Ming-Xi
Li, Xue-Mei
Zheng, Ke
author_sort Chen, Ru-Xuan
collection PubMed
description BACKGROUND: Lipodystrophy syndromes are rare disorders of variable body fat loss associated with potentially serious metabolic complications. Familial partial lipodystrophy (FPLD) is mostly inherited as an autosomal dominant disorder. Renal involvement has only been reported in a limited number of cases of FPLD. Herein, we present a rare case of proteinuria associated with type 4 FPLD, which is characterized by a heterozygous mutation in PLIN1 and has not been reported with renal involvement until now. CASE PRESENTATION: A 15-year-old girl presented with insulin resistance, hypertriglyceridaemia, hepatic steatosis and proteinuria. Her glucose and glycated haemoglobin levels were within normal laboratory reference ranges. A novel heterozygous frameshift mutation in PLIN1 was identified in the patient and her mother. The kidney biopsy showed glomerular enlargement and focal segmental glomerulosclerosis under light microscopy; the electron microscopy results fit with segmental thickening of the glomerular basement membrane. Treatment with an angiotensin-converting enzyme inhibitor (ACEI) decreased 24-h protein excretion. CONCLUSIONS: We report the first case of proteinuria and renal biopsy in a patient with FPLD4. Gene analysis demonstrated a novel heterozygous frameshift mutation in PLIN1 in this patient and her mother. Treatment with ACEI proved to be beneficial.
format Online
Article
Text
id pubmed-5946515
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59465152018-05-17 The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature Chen, Ru-Xuan Zhang, Lei Ye, Wei Wen, Yu-Bing Si, Nuo Li, Hang Li, Ming-Xi Li, Xue-Mei Zheng, Ke BMC Nephrol Case Report BACKGROUND: Lipodystrophy syndromes are rare disorders of variable body fat loss associated with potentially serious metabolic complications. Familial partial lipodystrophy (FPLD) is mostly inherited as an autosomal dominant disorder. Renal involvement has only been reported in a limited number of cases of FPLD. Herein, we present a rare case of proteinuria associated with type 4 FPLD, which is characterized by a heterozygous mutation in PLIN1 and has not been reported with renal involvement until now. CASE PRESENTATION: A 15-year-old girl presented with insulin resistance, hypertriglyceridaemia, hepatic steatosis and proteinuria. Her glucose and glycated haemoglobin levels were within normal laboratory reference ranges. A novel heterozygous frameshift mutation in PLIN1 was identified in the patient and her mother. The kidney biopsy showed glomerular enlargement and focal segmental glomerulosclerosis under light microscopy; the electron microscopy results fit with segmental thickening of the glomerular basement membrane. Treatment with an angiotensin-converting enzyme inhibitor (ACEI) decreased 24-h protein excretion. CONCLUSIONS: We report the first case of proteinuria and renal biopsy in a patient with FPLD4. Gene analysis demonstrated a novel heterozygous frameshift mutation in PLIN1 in this patient and her mother. Treatment with ACEI proved to be beneficial. BioMed Central 2018-05-10 /pmc/articles/PMC5946515/ /pubmed/29747582 http://dx.doi.org/10.1186/s12882-018-0913-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Chen, Ru-Xuan
Zhang, Lei
Ye, Wei
Wen, Yu-Bing
Si, Nuo
Li, Hang
Li, Ming-Xi
Li, Xue-Mei
Zheng, Ke
The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature
title The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature
title_full The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature
title_fullStr The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature
title_full_unstemmed The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature
title_short The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature
title_sort renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946515/
https://www.ncbi.nlm.nih.gov/pubmed/29747582
http://dx.doi.org/10.1186/s12882-018-0913-6
work_keys_str_mv AT chenruxuan therenalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT zhanglei therenalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT yewei therenalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT wenyubing therenalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT sinuo therenalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT lihang therenalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT limingxi therenalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT lixuemei therenalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT zhengke therenalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT chenruxuan renalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT zhanglei renalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT yewei renalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT wenyubing renalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT sinuo renalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT lihang renalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT limingxi renalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT lixuemei renalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature
AT zhengke renalmanifestationsoftype4familialpartiallipodystrophyacasereportandreviewofliterature